Early Phase Clinical Trial Units (EPCTU)
Award Notice Posted
- Solicitation number
- 75N93022D00019
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Duke University
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93022D00019 Federal IDV award
Notice details come from SAM.gov. Updated .
About this opportunity
The Award Notice was published by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases for the Early Phase Clinical Trial Units contract. The notice awards Duke University a contract valued at $346,610,277 to implement Phase 0 to Phase II clinical trials, including proof-of-concept studies domestically and internationally, for new or tested investigational products such as small molecules, monoclonal antibodies, immunoglobulins, convalescent plasma, passive transfer studies, vaccines, adjuvants, and other immunomodulatory products against infectious diseases through January 14, 2022.
Notice text
See Attachment for RFP-NIAID-NIH-AI-75N93020R00023.
Awarded contract 75N93022D00019 to Duke University for 346610277.00 on 2022-01-14.
Files
| File | Type | Posted |
|---|---|---|
| RFP-NIAID-NIH-AI-75N93020R00023 Final.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Early Phase Clinical Trial Units (EPCTU) | Award Notice | |
| Early Phase Clinical Trial Units (EPCTU) | Award Notice | |
| Early Phase Clinical Trial Units (EPCTU) | Award Notice | |
| Early Phase Clinical Trial Units (EPCTU) | Solicitation | |
| Early Phase Clinical Trial Units (EPCTU) | Pre-Solicitation |
6 of 7 notices listed here. See the rest on GovTribe.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity